BioTissue Technologies AG
BioTissue AG english
BioTissue Technologies AG changes from the Neuer Markt to the Geregelter Markt
Corporate-news announcement sent by DGAP.
The sender is solely responsible for the contents of this announcement.
——————————————————————————–
BioTissue Technologies AG changes from the Neuer Markt to the Geregelter Markt
(General Standard)
Freiburg, 23rd April 2003 – The Management Board and Supervisory Board of
BioTissue Technologies AG (SIN 618061, ISIN DE 000 618061 5) have decided to
change from the Neuer Markt to the Geregelter Markt (General Standard). Deutsche
Boerse AG agreed to this change on 23rd April 2003. The last listing on the
Neuer Markt is to take place on 25th April 2003 and the listing in the
Geregelter Markt (General Standard) is to be accepted on 28th April 2003.
The change to the Geregelter Markt (General Standard) is a further step, along
with intensive international marketing activities, towards improving the
company’s profitability by reducing costs and carrying out consolidation
measures.
Contact: BioTissue Technologies AG, Engesserstraße 4a / 4b, D-79108 Freiburg,
Dr. Victor Tiegermann, Chief Executive Officer, Tel. +49 (0) 7 61 76 76-100,
Fax +49 (0) 7 61 76 76-150, ir@biotissue-tec.com, http://www.biotissue-tec.com
end of message, (c)DGAP 23.04.2003
——————————————————————————–
WKN: 618061; ISIN: DE0006180615; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin-Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
230802 Apr 03
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden